The Science of Radiofrequency Renal Denervation
The Science of Radiofrequency Renal Denervation webinar is a two part video series that will introduce the key concepts critical to understanding the basic mechanism of RF ablation for Renal Denervation. The series is hosted by Prof Andrew Sharp and Dr Stefan Tunev.
The first part of the series, The Science of Radiofrequency Renal Denervation - Part 1, is available on-demand and it is recommended that attendees watch this in advance of the live Part 2, to maximise the learnings from this live session.
In this live Part 2, Prof Sharp will open with a short recap of Part 1, followed by the second part of the video, then a Q&A session, where Prof Sharp and Dr Tunev will be available to answer your questions live. This session will be 1 hour in total.
Andrew SP Sharp
This webinar is supported by
- Understand the importance of renal anatomy and nerve location on ablation effectiveness
- Confirm the safety and efficacy of RF as an ablation mechanism
- Learn the latest on measuring ablation effectiveness and the relevance of ablation depth
- Examine the functional and physiological evidence around nerve regrowth and RDN durability
Veterinary Pathologist, Fellow in Comparative Medicine, specializing in the field of medical device pathology
Andrew SP Sharp
Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.
Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.
Andrew's specialist interests include the pharmacological and interventional treatment of resistant hypertension (including renal denervation); intra-coronary physiology to assess the causes of chest pain; complex angioplasty and stenting of coronary artery disease and CT coronary angiography.
Dr Andrew Sharp is Deputy Editor (Development) of Interventional Cardiology: Reviews, Research, Resources (ICR3)